Kramer was the CEO of Emergent BioSolutions, a government contractor hired to mass produce coronavirus vaccine doses, 400 ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...
A former chief executive of Emergent BioSolutions was charged on Thursday with insider trading by New York Attorney General ...
New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...
New York Attorney General Letitia James filed suit against the former head of Emergent BioSolutions, accusing him of insider trading for selling his shares in the company before disclosing ...
The Oxford-AstraZeneca Covid vaccine showed what is possible when long-term choices deliver rapid and lasting benefits for ...